Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21265 | 366 | 32.0 | 62% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PROBUCOL | Author keyword | 19 | 20% | 23% | 85 |
| 2 | AGI 1067 | Author keyword | 8 | 75% | 2% | 6 |
| 3 | SUCCINOBUCOL | Author keyword | 2 | 38% | 1% | 5 |
| 4 | PROBUCOL ANALOG | Author keyword | 1 | 50% | 1% | 2 |
| 5 | VASCULAR PROTECTANT | Author keyword | 1 | 100% | 1% | 2 |
| 6 | INTRAVASC ULTRASOUND | Address | 1 | 40% | 1% | 2 |
| 7 | ANTIHYPERLIPOPROTEINEMIC DRUG | Author keyword | 1 | 50% | 0% | 1 |
| 8 | APOPTOSIS SIGNAL | Author keyword | 1 | 50% | 0% | 1 |
| 9 | CHOLESTEROL ESTER TRANSFER ACTIVITY | Author keyword | 1 | 50% | 0% | 1 |
| 10 | CORONARY VESSELS STENOSIS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PROBUCOL | 19 | 20% | 23% | 85 | Search PROBUCOL | Search PROBUCOL |
| 2 | AGI 1067 | 8 | 75% | 2% | 6 | Search AGI+1067 | Search AGI+1067 |
| 3 | SUCCINOBUCOL | 2 | 38% | 1% | 5 | Search SUCCINOBUCOL | Search SUCCINOBUCOL |
| 4 | PROBUCOL ANALOG | 1 | 50% | 1% | 2 | Search PROBUCOL+ANALOG | Search PROBUCOL+ANALOG |
| 5 | VASCULAR PROTECTANT | 1 | 100% | 1% | 2 | Search VASCULAR+PROTECTANT | Search VASCULAR+PROTECTANT |
| 6 | ANTIHYPERLIPOPROTEINEMIC DRUG | 1 | 50% | 0% | 1 | Search ANTIHYPERLIPOPROTEINEMIC+DRUG | Search ANTIHYPERLIPOPROTEINEMIC+DRUG |
| 7 | APOPTOSIS SIGNAL | 1 | 50% | 0% | 1 | Search APOPTOSIS+SIGNAL | Search APOPTOSIS+SIGNAL |
| 8 | CHOLESTEROL ESTER TRANSFER ACTIVITY | 1 | 50% | 0% | 1 | Search CHOLESTEROL+ESTER+TRANSFER+ACTIVITY | Search CHOLESTEROL+ESTER+TRANSFER+ACTIVITY |
| 9 | CORONARY VESSELS STENOSIS | 1 | 50% | 0% | 1 | Search CORONARY+VESSELS++STENOSIS | Search CORONARY+VESSELS++STENOSIS |
| 10 | HFL1 CELLS | 1 | 50% | 0% | 1 | Search HFL1+CELLS | Search HFL1+CELLS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AGI 1067 | 9 | 67% | 2% | 8 |
| 2 | SWEDISH TRIAL PQRST | 3 | 33% | 2% | 7 |
| 3 | PREVENTING RESTENOSIS | 2 | 25% | 2% | 7 |
| 4 | HYPERCHOLESTEROLEMIC WATANABE RABBITS | 2 | 26% | 2% | 6 |
| 5 | FEMORAL ATHEROSCLEROSIS | 2 | 14% | 3% | 10 |
| 6 | ANGIOPLASTY RESTENOSIS TRIAL | 1 | 100% | 1% | 2 |
| 7 | PROBUCOL PROTECTS | 1 | 100% | 1% | 2 |
| 8 | ANTIOXIDANT PROBUCOL | 1 | 40% | 1% | 2 |
| 9 | INTERLEUKIN 1 SECRETION | 1 | 20% | 1% | 4 |
| 10 | HYPERCHOLESTEROLEMIA INDUCED ATHEROSCLEROSIS | 1 | 18% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Where are we with probucol: A new life for an old drug? | 2009 | 62 | 50 | 38% |
| PROBUCOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN HYPERCHOLESTEROLEMIA | 1989 | 117 | 82 | 62% |
| Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues | 2009 | 20 | 66 | 44% |
| PROBUCOL - PHARMACOLOGY AND CLINICAL-APPLICATION | 1990 | 35 | 26 | 54% |
| Oxidative stress as a signaling mechanism of the vascular response to injury: The redox hypothesis of restenosis | 2000 | 97 | 69 | 19% |
| Did we abandon probucol too soon? | 2015 | 0 | 103 | 50% |
| Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds | 2008 | 7 | 101 | 36% |
| PROBUCOL IN LONG-TERM TREATMENT OF HYPERCHOLESTEROLEMIA | 1988 | 13 | 32 | 84% |
| CHOLESTEROL TURNOVER IN TRIGLYCERIDE TRANSPORT AND PROBUCOL ACTION | 1995 | 1 | 53 | 58% |
| ANTIOXIDANT ACTIVITY AND SERUM LEVELS OF PROBUCOL AND PROBUCAL METABOLITES | 1994 | 17 | 21 | 29% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTRAVASC ULTRASOUND | 1 | 40% | 0.5% | 2 |
| 2 | FREE RAD PROJECT | 1 | 25% | 0.5% | 2 |
| 3 | KRANKENHAUS EPPENDORF MED KERNKLIN POLIKLIN | 0 | 33% | 0.3% | 1 |
| 4 | PHARMACOL CLIN PHARMACOL THER EUT | 0 | 33% | 0.3% | 1 |
| 5 | VASC BIOMECH | 0 | 33% | 0.3% | 1 |
| 6 | ATHEROSCLEROT DIS | 0 | 11% | 0.8% | 3 |
| 7 | LIPOPROT METAB | 0 | 14% | 0.5% | 2 |
| 8 | CAHRITE | 0 | 25% | 0.3% | 1 |
| 9 | GENOM BASED DRUG DISCOVERY | 0 | 25% | 0.3% | 1 |
| 10 | JONANKU | 0 | 25% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000220150 | OXIDIZED LDL//LOW DENSITY LIPOPROTEIN//LIPOPROTEIN OXIDATION |
| 2 | 0.0000164004 | PRAVASTATIN//HMG COA REDUCTASE INHIBITOR//COMPACTIN |
| 3 | 0.0000140142 | APA HAMSTER//APA HAMSTERS//ATHEROMATOUS LESION |
| 4 | 0.0000110376 | FENOFIBRIC ACID//FENOFIBRATE//FIBRATES |
| 5 | 0.0000106131 | PARTIAL ILEAL BYPASS//POSCH//ATHEROGENIC RATIO |
| 6 | 0.0000099361 | CHOLESTERYL ESTER TRANSFER PROTEIN//PHOSPHOLIPID TRANSFER PROTEIN//CETP |
| 7 | 0.0000092325 | CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//CAS 73963 72 1 |
| 8 | 0.0000080804 | PREVU POC SKIN STEROL TEST//SKIN TISSUE CHOLESTEROL//ATHEROSCLEROSIS REVERSAL CLIN |
| 9 | 0.0000066795 | LOCAL DRUG DELIVERY//HIRULOG LIKE PEPTIDE//ANGIOPEPTIN |
| 10 | 0.0000063139 | LAROPIPRANT//NIACIN//HM74A |